Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features

Author:

Hassan Sk. SarifORCID,Ghosh Shinjini,Attrish Diksha,Choudhury Pabitra PalORCID,Aljabali Alaa A. A.ORCID,Uhal Bruce D.ORCID,Lundstrom Kenneth,Rezaei NimaORCID,Uversky Vladimir N.ORCID,Seyran Murat,Pizzol DamianoORCID,Adadi PariseORCID,Soares Antonio,El-Aziz Tarek Mohamed AbdORCID,Kandimalla RameshORCID,Tambuwala Murtaza M.ORCID,Azad Gajendra KumarORCID,Sherchan Samendra P.,Baetas-da-Cruz Wagner,Takayama KazuoORCID,Serrano-Aroca ÁngelORCID,Chauhan Gaurav,Palu Giorgio,Brufsky Adam M.ORCID

Abstract

Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is engendering the severe coronavirus disease 2019 (COVID-19) pandemic. The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-domains viz. amino acids (aa) 22–42, aa 79–84, and aa 330–393 of ACE2 on human cells to initiate entry. It was reported earlier that the receptor utilization capacity of ACE2 proteins from different species, such as cats, chimpanzees, dogs, and cattle, are different. A comprehensive analysis of ACE2 receptors of nineteen species was carried out in this study, and the findings propose a possible SARS-CoV-2 transmission flow across these nineteen species.

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference48 articles.

1. Severe acute respiratory syndrome (SARS);Wkly. Epidemiol. Rec.,2003

2. Outbreak news: Severe acute respiratory syndrome (SARS);Wkly. Epidemiol. Rec.,2003

3. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

4. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

5. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3